CCAT2 and breast cancer: Consistently, a decrease in CCAT2 was observed in both luminal A and luminal B breast tumor samples, compared to matched adjacent normal mammary tissues (Figure 1B), which was further confirmed in 609 luminal breast cancer tumors from the TCGA database (Figure 1C).